0001628280-23-020835.txt : 20230605
0001628280-23-020835.hdr.sgml : 20230605
20230605151944
ACCESSION NUMBER: 0001628280-23-020835
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230601
FILED AS OF DATE: 20230605
DATE AS OF CHANGE: 20230605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Calloway Nathaniel
CENTRAL INDEX KEY: 0001952771
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-27446
FILM NUMBER: 23992163
MAIL ADDRESS:
STREET 1: C/O ANEBULO PHARMACEUTICALS, INC.
STREET 2: 1415 RANCH ROAD 620 SOUTH, SUITE 201
CITY: LAKEWAY
STATE: TX
ZIP: 78734
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIFECORE BIOMEDICAL, INC. \DE\
CENTRAL INDEX KEY: 0001005286
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943025618
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0528
BUSINESS ADDRESS:
STREET 1: 3515 LYMAN BOULEVARD
CITY: CHASKA
STATE: MN
ZIP: 55318
BUSINESS PHONE: 9523684300
MAIL ADDRESS:
STREET 1: 3515 LYMAN BOULEVARD
CITY: CHASKA
STATE: MN
ZIP: 55318
FORMER COMPANY:
FORMER CONFORMED NAME: LANDEC CORP \CA\
DATE OF NAME CHANGE: 19951222
4
1
wk-form4_1685992772.xml
FORM 4
X0407
4
2023-06-01
0
0001005286
LIFECORE BIOMEDICAL, INC. \DE\
LFCR
0001952771
Calloway Nathaniel
C/O LIFECORE BIOMEDICAL, INC.
3515 LYMAN BLVD
CHASKA
MN
55318
1
0
0
0
0
Common Stock
2023-06-01
4
A
0
18182
A
18182
D
The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
Restricted Stock Units will vest and be settled on the earlier of the 1st anniversary of the grant date or the date of the 2024 Annual Meeting of Stockholders (provided such date is no less than 50 weeks from Grant Date).
/s/ Rebecca Hilt, Attorney-In-Fact for Nathaniel Calloway
2023-06-05